The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease.
from NYT > Top Stories https://ift.tt/3701CCf
https://ift.tt/eA8V8J
j34FF5
No comments:
Post a Comment